
SAMSARA BIOCAPITAL, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | KLRS | 11.45M | $66.17M |
![]() | MLYS | 6.26M | $237.50M |
![]() | GOSS | 6.13M | $16.12M |
![]() | SRRK | 5.61M | $209.02M |
![]() | ALMS | 4.80M | $19.16M |
![]() | NKTX | 3.77M | $7.80M |
![]() | SEPN | 3.15M | $59.24M |
![]() | AQST | 2.50M | $13.97M |
![]() | STRO | 2.20M | $1.91M |
![]() | NGNE | 1.72M | $29.76M |
![]() | UPB | 962K | $18.10M |
![]() | AVDL | 676K | $10.31M |
![]() | AURA | 585K | $3.61M |
![]() | CTNM | 571K | $6.71M |
![]() | JBIO | 531K | $4.58M |
![]() | VTVT | 374K | $8.74M |
![]() | LENZ | 343K | $15.98M |
![]() | SRZN | 241K | $3.11M |
![]() | PVLA | 210K | $13.14M |
![]() | ZYME | 208K | $3.55M |

Kalaris Therapeutics Inc
KLRS
Shares Held
11.45M
Value
$66.17M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
6.26M
Value
$237.50M

Gossamer Bio, Inc.
GOSS
Shares Held
6.13M
Value
$16.12M

Scholar Rock Holding Corporation
SRRK
Shares Held
5.61M
Value
$209.02M

Alumis Inc. Common Stock
ALMS
Shares Held
4.80M
Value
$19.16M

Nkarta, Inc.
NKTX
Shares Held
3.77M
Value
$7.80M

Septerna, Inc.
SEPN
Shares Held
3.15M
Value
$59.24M

Aquestive Therapeutics, Inc.
AQST
Shares Held
2.50M
Value
$13.97M

Sutro Biopharma, Inc.
STRO
Shares Held
2.20M
Value
$1.91M

Neurogene Inc.
NGNE
Shares Held
1.72M
Value
$29.76M

Upstream Bio, Inc.
UPB
Shares Held
962K
Value
$18.10M

Avadel Pharmaceuticals plc
AVDL
Shares Held
676K
Value
$10.31M

Aura Biosciences, Inc.
AURA
Shares Held
585K
Value
$3.61M

Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
571K
Value
$6.71M

Jade Biosciences, Inc.
JBIO
Shares Held
531K
Value
$4.58M

vTv Therapeutics Inc.
VTVT
Shares Held
374K
Value
$8.74M

LENZ Therapeutics, Inc.
LENZ
Shares Held
343K
Value
$15.98M

Surrozen, Inc.
SRZN
Shares Held
241K
Value
$3.11M

Palvella Therapeutics, Inc.
PVLA
Shares Held
210K
Value
$13.14M

Zymeworks Inc.
ZYME
Shares Held
208K
Value
$3.55M
